Kevin Outterson

Boston University School of Law

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Maple Feng Goh

Assistant Professor

Tufts University

UNITED STATES

View details

ELIAS MOSSIALOS

Professor of Health Policy

London School of Economics and Political Science

UNITED KINGDOM

View details

Michael Anderson

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kevin Outterson

Research Interests

Explore related searches

Contact this professor

Articles (13)

Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27

Changes in revenues associated with antimicrobial reimbursement reforms in Germany

Implementing an EU pull incentive for antimicrobial innovation and access: blueprint for action

Global Pull Incentives for Better Antibacterials: The UK Leads the Way

Trends in the global antibiotics market

Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020

A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial Effectiveness

Introduction: AMR Belongs in the Pandemic Instrument

Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines

The impact of infections on reimbursement in 92 US hospitals, 2015-2018

The effect of generic market entry on antibiotic prescriptions in the United States

Collaborators (3)

Maple Feng Goh

ELIAS MOSSIALOS

Michael Anderson

Make your next move.